Logo image of SHC

SOTERA HEALTH CO (SHC) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SHC - US83601L1026 - Common Stock

19.18 USD
-0.17 (-0.88%)
Last: 1/16/2026, 8:00:02 PM
19.18 USD
0 (0%)
After Hours: 1/16/2026, 8:00:02 PM

SHC Key Statistics, Chart & Performance

Key Statistics
Market Cap5.45B
Revenue(TTM)1.15B
Net Income(TTM)55.42M
Shares284.09M
Float204.08M
52 Week High19.85
52 Week Low9.53
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)0.81
PE23.68
Fwd PE20.12
Earnings (Next)02-24
IPO2020-11-20
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
SHC short term performance overview.The bars show the price performance of SHC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60

SHC long term performance overview.The bars show the price performance of SHC in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40

The current stock price of SHC is 19.18 USD. In the past month the price increased by 14.1%. In the past year, price increased by 47.77%.

SOTERA HEALTH CO / SHC Daily stock chart

SHC Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to SHC. When comparing the yearly performance of all stocks, SHC is one of the better performing stocks in the market, outperforming 88.26% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SHC Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to SHC. While SHC has a great profitability rating, there are quite some concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SHC Financial Highlights

Over the last trailing twelve months SHC reported a non-GAAP Earnings per Share(EPS) of 0.81. The EPS increased by 8% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.82%
ROA 1.74%
ROE 10.07%
Debt/Equity 4.04
Chartmill High Growth Momentum
EPS Q2Q%52.94%
Sales Q2Q%9.05%
EPS 1Y (TTM)8%
Revenue 1Y (TTM)-15.95%

SHC Forecast & Estimates

14 analysts have analysed SHC and the average price target is 20.85 USD. This implies a price increase of 8.69% is expected in the next year compared to the current price of 19.18.

For the next year, analysts expect an EPS growth of 20.58% and a revenue growth 5.31% for SHC


Analysts
Analysts82.86
Price Target20.85 (8.71%)
EPS Next Y20.58%
Revenue Next Year5.31%

SHC Ownership

Ownership
Inst Owners58.12%
Ins Owners2.34%
Short Float %3.5%
Short Ratio2.84

SHC Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 27.62 232.46B
DHR DANAHER CORP 30.61 166.69B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28 188.8 57.37B
IQV IQVIA HOLDINGS INC 20.44 40.48B
A AGILENT TECHNOLOGIES INC 25.03 39.59B
MTD METTLER-TOLEDO INTERNATIONAL 34.91 29.84B
WAT WATERS CORP 30.5 23.06B
ILMN ILLUMINA INC 32.49 21.64B
WST WEST PHARMACEUTICAL SERVICES 36.75 18.69B
MEDP MEDPACE HOLDINGS INC 42.72 17.21B
RVTY REVVITY INC 23.49 12.76B
TEM TEMPUS AI INC N/A 12.51B

Related stock screener links

About SHC

Company Profile

SHC logo image Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Company Info

SOTERA HEALTH CO

9100 South Hills Blvd, Suite 300, Suite 300

Broadview Heights OHIO 44147 US

CEO: Michael B. Petras

Employees: 3000

SHC Company Website

SHC Investor Relations

Phone: 14402621410

SOTERA HEALTH CO / SHC FAQ

What does SHC do?

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.


What is the stock price of SOTERA HEALTH CO today?

The current stock price of SHC is 19.18 USD. The price decreased by -0.88% in the last trading session.


Does SHC stock pay dividends?

SHC does not pay a dividend.


How is the ChartMill rating for SOTERA HEALTH CO?

SHC has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the growth outlook for SOTERA HEALTH CO?

The Revenue of SOTERA HEALTH CO (SHC) is expected to grow by 5.31% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


When does SOTERA HEALTH CO (SHC) report earnings?

SOTERA HEALTH CO (SHC) will report earnings on 2026-02-24, after the market close.


What is the outstanding short interest for SOTERA HEALTH CO?

The outstanding short interest for SOTERA HEALTH CO (SHC) is 3.5% of its float.